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Abstract
 
Introduction
Few studies have prospectively assessed the explana-
tory effects of demographics, clinical conditions, treatment 
modality,  and  general  lifestyle  behaviors  on  glycemic 
control  in  large  heterogeneous  samples  of  middle-aged 
and older adults with type 2 diabetes. We hierarchically 
examined these factors, focused especially on the effects 
of modifiable factors (ie, general lifestyle behaviors), and 
compared  predictive  patterns  between  middle-aged  and 
older adults.
 
Methods
We used nationally representative data from the 1998 
and 2000 Health and Retirement Study (HRS) and the HRS 
2003 Diabetes Study. We analyzed data from 379 middle-
aged adults (aged 51-64 y) and 430 older adults (aged ≥65 y) 
who self-reported having type 2 diabetes at baseline.
 
Results
Among  middle-aged  adults,  demographic  factors  and 
clinical conditions were the strongest predictors of hemo-
globin A1c (HbA1c) levels. However, among older adults, 
treatment modality (diet only, oral medication, or insulin 
only or in combination with other regimens) significantly 
affected HbA1c levels. Lifestyle (physical activity, smok-
ing, drinking, and body weight control), independent of the 
effects of demographics, clinical conditions, and treatment 
modality, significantly affected HbA1c levels. An increase 
of 1 healthy behavior was associated with a decrease in 
HbA1c levels of more than 1 percentage point.
 
Conclusion
Our findings provide support for current diabetes guide-
lines that recommend a lifestyle regimen across the entire 
span  of  diabetes  care  and  highlight  the  need  to  help 
both  sociodemographically  and  clinically  disadvantaged 
middle-aged adults with type 2 diabetes as well as older 
adults who exhibit poor adherence to medication recom-
mendations to achieve better glycemic control.
Introduction
 
Type 2 diabetes affects a large number of middle-aged 
and older adults in the United States. More than 16 mil-
lion adults in the United States and 200 million people 
worldwide have the disease (1). One of the primary goals 
of diabetes management is to lower blood glucose levels 
because it is well established that improved glycemic con-
trol delays the onset and retards the progression of micro-
vascular and macrovascular complications (2). However, 
many  US  adults  (40%-60%)  with  type  2  diabetes  have 
poor glycemic control (3,4). Understanding the factors that 
contribute to glycemic control is key to developing more 
effective  treatment  and  identifying  the  needs  of  adults 
with type 2 diabetes.
 
Lifestyle  behaviors  are  postulated  to  play  a  role  in 
glycemic  control,  and  their  effects  on  glycemic  control 
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have been given increasing attention in the past decade. 
However, most studies in this area have focused only on 
the effects of diabetes-specific self-management behaviors 
on glycemic control (5-7). Furthermore, other studies that 
have demonstrated the effects of general health behaviors 
on hemoglobin A1c (HbA1c) levels have focused on a single 
lifestyle behavior, such as exercise or weight control (8,9). 
Although findings from these studies have been encourag-
ing, most studies have examined changes in HbA1c levels 
among homogeneous samples within a short period after 
the  strictly  controlled  intervention.  The  effectiveness  of 
general lifestyle behaviors on long-term glycemic control 
among adults from heterogeneous backgrounds, with dif-
fering clinical conditions, and who use different forms of 
treatment remains uncertain.
 
The  influences  of  demographics,  clinical  conditions, 
and treatment adherence on glycemic control have also 
been documented. Previous studies have suggested that 
minority  groups  (eg,  African  Americans,  Hispanics, 
American Indians, Pacific Islanders) (10,11) and adults 
who  have  had  diabetes  for  a  long  time,  who  have 
comorbidities  (12,13),  or  who  use  insulin  or  multiple 
oral  agents  have  high  HbA1c  levels  (12,14).  However, 
longitudinal evidence regarding the explanatory effects 
of these variables on glycemic control from large hetero-
geneous national samples is sparse. Because these fac-
tors have not been examined comprehensively, whether 
clinical  conditions  explain  the  racial/ethnic  disparities 
or whether the effect of clinical conditions on glycemic 
control differs among people from different demographic 
backgrounds is unclear.
 
Furthermore, there has been little investigation of the 
predictive factors of glycemic control in midlife and older 
age. As suggested by cumulative advantage/disadvantage 
theory, age has a modifying effect on many explanatory 
factors  in  health  outcomes  (15).  Therefore,  we  hypoth-
esized that distinct predictive patterns of glycemic control 
exist between middle-aged and older adults. The effects 
of dietary therapy on glycemic control in clinical settings 
generally  deteriorate  over  time  (14).  However,  current 
literature does not answer the question of whether older 
adults are less sensitive to other modifiable factors, such 
as health behaviors.
 
We prospectively examined the effects of general life-
style  behaviors  (physical  activity,  smoking,  drinking, 
and  weight  control)  on  HbA1c  levels,  controlling  for 
documented correlates, including demographic character-
istics (4,16,17), clinical conditions (12,13), and treatment 
modalities (14,18). We studied a nationally representative 
sample of middle-aged and older adults with type 2 dia-
betes. We demonstrate the complex explanatory effects of 
each factor on glycemic control by using a heterogeneous 
sample,  longitudinal  design,  and  hierarchical  regres-
sion analysis. We tested the hierarchical models among 
middle-aged adults and older adults separately to examine 
whether distinct predictive patterns between middle-aged 
and older adults exist.
Methods
Participants
 
Our  study  sample  was  379  middle-aged  adults  (aged 
51-64 y) and 430 older adults (aged ≥65 y) who 1) in the 
1998 Health and Retirement Study (HRS) interview self-
reported having diagnosed type 2 diabetes after age 34 
and 2) returned valid blood spot tests for HbA1c in the 
2003 HRS Diabetes Study.
 
The HRS is an ongoing biennial survey that was initi-
ated in 1992 to track the health status and retirement 
plans of community-dwelling middle-aged and older US 
adults  and  that  oversamples  Hispanic  Americans  and 
African Americans. Details about recruitment procedures 
and characteristics of the participants in the HRS inter-
view are described elsewhere (19). The HRS 2003 Diabetes 
Study followed adults who self-reported diagnosed diabetes 
in the 2002 or earlier HRS interviews and collected data 
on various diabetes-related psychological, behavioral, and 
clinical measures. We weighted data to make the study 
sample representative of US middle-aged and older adults 
with type 2 diabetes who were born in 1947 or earlier (ie, 
aged 51 or older in 1998).
Measures
 
Demographic  characteristics  (age,  sex,  race/ethnicity, 
education, and marital status) were obtained from 1998 
HRS  data.  Age  and  education  were  measured  as  con-
tinuous variables. Race/ethnicity was categorized as non-
Hispanic white, non-Hispanic black, and Hispanic/other. 
Marital status was measured as a dichotomous variable 
(married/partnered or other).
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Measures of clinical conditions, including the number 
of  self-reported  physical  or  psychological  chronic  condi-
tions  and  the  duration  of  diabetes,  were  obtained  from 
2000 HRS data. The number of physical or psychological 
chronic diseases was the sum of indicators for whether a 
participant had ever been informed by a doctor that he or 
she ever had high blood pressure, diabetes, cancer, lung 
disease,  heart  disease,  stroke,  psychiatric  problems,  or 
arthritis. The duration of diabetes was calculated as the 
number of years between individuals’ diagnosis of diabetes 
and the year 2000. Information about the age of diagnosis 
of diabetes was obtained from the question, “At what age 
were you told by a doctor that you had diabetes?”
 
Information about treatment modality was obtained by 
participants’ answers to 3 questions from the 2000 HRS: 
“Are you following a special diet?,” “In order to treat or 
control your diabetes, are you now taking medication that 
you swallow?,” and “Are you now using insulin shots or a 
pump?” Participants who answered yes to the diet question 
but did not report using oral medications or insulin were 
placed in the “diet only” treatment group, participants who 
reported using oral medications only or a combination of 
oral medication and diet but did not report using insulin 
were placed in the “oral medication” treatment group, and 
participants who reported using insulin only or in com-
bination with other regimens were placed in the “insulin 
only or combination” treatment group.
 
Self-reported  information  obtained  in  the  2000  HRS 
about  lifestyle  behaviors  related  to  physical  activity, 
substance use, and control of body weight were used. To 
report physical activity, participants were asked the yes/
no question, “On average over the last 12 months have 
you participated in vigorous activity or exercise 3 times a 
week or more?” Substance use was assessed by asking, “Do 
you smoke cigarettes now?,” “Have you ever felt that you 
should cut down on drinking?,” “Have people ever annoyed 
you by criticizing your drinking?,” “Have you ever felt bad 
or guilty about drinking?,” or “Have you ever taken a drink 
first thing in the morning to steady your nerves or get rid 
of a hangover?” Participants who answered no to all ques-
tions were defined as “no substance use”; all others were 
defined as “substance use.” Body mass index (BMI) was 
used  to  determine  control  of  body  weight.  Participants 
were  categorized  as  either  having  body  weight  control 
(BMI <30 kg/m2) or not (BMI ≥30 kg/m2), on the basis of 
National Heart, Lung, and Blood Institute guidelines (20). 
We recoded the responses to the above behaviors into 3 
categories for lifestyle: poor (0 positive health behaviors), 
fair  (1  positive  health  behavior),  and  good  (≥2  positive 
health behaviors).
 Glycemic control was determined by HbA1c levels. This 
biomarker was available through blood spot assays col-
lected in the HRS 2003 Diabetes Study.
Data analysis
 
SAS version 9.1 (SAS Institute, Inc, Cary, North Carolina) 
was used to analyze the data. To characterize the sample 
across  major  study  variables  and  to  test  their  associa-
tion with HbA1c levels, we performed t tests, analysis of 
variance  (ANOVA),  and  simple  regression.  Hierarchical 
multiple  regression  analyses  were  conducted  to  answer 
the study’s specific research questions. Significance was 
set at P < .05. In model 1, only demographic variables (age 
and race/ethnicity) were entered as explanatory variables; 
in model 2, we added clinical condition variables (number 
of chronic diseases, duration of diabetes); in model 3, we 
added treatment modality variables (diet only, oral medi-
cation, or insulin use); and in model 4, we added a lifestyle 
variable  (fair,  good,  or  poor).  Significance  tests  for  R2 
increment were calculated to provide information on how 
well the sequential variables accounted for the variance 
in HbA1c levels beyond that accounted for by variables in 
the preceding model. To explore possible differences in the 
predictive patterns between middle-aged and older adults, 
the models were tested for the entire sample and sepa-
rately for the middle-aged and older adult samples.
Results
Sample characteristics and bivariate analysis with HbA1c 
levels
 
Glycemic control was significantly associated with age, 
race/ethnicity,  number  of  chronic  diseases,  duration  of 
diabetes, treatment modality, and lifestyle (Table 1). Age 
was negatively correlated with HbA1c values. Participants 
who  were  non-Hispanic  white,  reported  fewer  chronic 
diseases, reported a shorter duration of diabetes, reported 
using diet-only treatment, or reported having good life-
style behaviors had lower HbA1c levels. Sex, education, 
and marital status were not significantly associated with 
HbA1c  levels  and  were  excluded  from  the  hierarchical 
regression analyses.VOLUME 7: NO. 1
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Effects of demographics, clinical conditions, treatment 
modality, and lifestyle on glycemic control
 
Model 1, which included only age and race/ethnicity as 
variables, explained 4.8% of the variance in HbA1c lev-
els (Table 2). Age was negatively associated with HbA1c 
levels, and non-Hispanic black and Hispanic participants 
had higher HbA1c levels than non-Hispanic white partici-
pants.
 
Model  2,  which  added  duration  of  diabetes  and  the 
number of chronic diseases as variables, explained 7.6% 
of the variance in HbA1c levels. A significance test of R2 
increment from model 1 to model 2 suggests that the clini-
cal conditions, over and above the demographic determi-
nants, explained a significant proportion of the variance 
in HbA1c levels. Participants who reported having more 
chronic diseases or a longer duration of diabetes had high-
er HbA1c levels than participants who reported having 
fewer chronic diseases or a shorter duration of diabetes, 
independent of the demographic determinants.
 
Model 3, which added treatment modality as a variable, 
explained  14.1%  of  the  variance  in  HbA1c  levels.  The 
change in R2 from model 2 to model 3 was significant, sug-
gesting that treatment modality has a substantial effect in 
predicting HbA1c levels, independent of demographic and 
clinical characteristics. Compared with participants who 
used insulin only or in combination with other regimens, 
participants who were treated with diet only or oral medi-
cations had lower HbA1c levels.
 
Although  demographic  characteristics,  clinical  condi-
tions, and treatment modality explained an appreciable 
amount  of  the  variance  in  HbA1c  levels,  an  additional 
2.1% of the variance was explained independently and sig-
nificantly by lifestyle behaviors. An increase of 1 healthy 
behavior was associated with a decrease in HbA1c levels 
of more than 1 percentage point.
Comparison of predictive patterns in middle-aged and 
older adults
 
In middle-aged adults, our selected predictors explained 
21.3%  of  the  total  variance  in  HbA1c  levels  (Table  3). 
Demographics  and  clinical  conditions  accounted  for  the 
largest  explained  variance.  Treatment  modality  also 
explained a significant proportion of the variance in HbA1c 
levels, as did lifestyle, which was added to model 4. The 
result suggests that, among middle-aged adults with type 
2 diabetes, lifestyle behaviors are strongly associated with 
HbA1c levels, independent of the effects of demographic 
background, clinical conditions, and treatment modality.
 
In the older adult group, our selected predictors explained 
10.2%  of  the  variance  in  HbA1c  levels,  approximately 
half  that  in  the  middle-aged  adult  sample  (Table  4). 
Demographics, clinical conditions, and lifestyle variables 
did not significantly predict HbA1c levels in older adults, 
but treatment modality did. The patterns of the 4 predic-
tors on glycemic control in the entire sample, as well as 
in  middle-aged  adults  and  older  adults  separately,  are 
presented in the Figure.
 
Discussion
 
Our results suggest that distinct predictive patterns of 
glycemic  control  exist  for  middle-aged  and  older  adults 
and  confirm  the  long-term  beneficial  link  between  gen-
eral  lifestyle  behaviors  and  HbA1c  levels,  especially  in 
middle-aged adults. The results also highlight the crucial 
role of medication treatment in older adults with type 2 
diabetes.
 
The result that nonwhite adults with type 2 diabetes 
were less likely to achieve adequate glycemic control than 
Figure. Effects of demographic factors, clinical conditions, treatment modal-
ity, and lifestyle on HbA1c levels among middle-aged adults (n = 79), older 
adults (n = 0), and the entire sample (N = 809), the 1998 and 2000 
Health and Retirement Study (HRS) and the HRS 200 Diabetes Study.VOLUME 7: NO. 1
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were their white counterparts is in accord with other stud-
ies  (4,10,11,21)  and  confirms  the  previous  finding  that 
mechanisms beyond our model covariates of clinical condi-
tions, treatment modality, and general lifestyle underlie 
racial/ethnic disparities in glycemic outcomes. Our find-
ing that younger age was associated with worse glycemic 
control is congruent with a previous study (17) and echoes 
other studies that suggest that early-onset type 2 diabetes 
is associated with worse glycemic control outcomes than 
is later-onset type 2 diabetes (22). Our finding that the 
number of chronic diseases and duration of diabetes, inde-
pendent  of  demographics,  predicted  glycemic  control  is 
consistent with at least 1 study (12). Although our results 
showed that diet-only therapy was associated with lower 
HbA1c levels and that using insulin only or in combination 
with other regimens is associated with higher HbA1c lev-
els, these relationships more likely represent a marker of 
diabetes severity than of medication effects themselves.
 
Of particular interest is the fact that demographic fac-
tors, clinical conditions and treatment modality explained 
a substantial proportion of the variance in HbA1c levels 
and that lifestyle behaviors independently explained 2.1% 
of the variance in HbA1c levels in the entire sample. The 
effect  did  not  vary  across  sex  and  racial/ethnic  groups, 
diabetes duration, number of chronic conditions, and dia-
betes treatment modality. The finding that an increase of 
1 healthy behavior is associated with a decrease in HbA1c 
levels of more than 1 percentage point is not only signifi-
cant but also clinically relevant.
 
Comparison of the predictive patterns between middle-
aged  adults  and  older  adults  reveals  that  in  midlife, 
demographic factors and clinical conditions are the most 
substantial predictors for HbA1c levels. This finding has 
practical  implications  for  diabetes  care.  Early  interven-
tions may be needed to help socioeconomically and clinical-
ly disadvantaged middle-aged adults with type 2 diabetes 
to achieve satisfactory glycemic control. Conversely, our 
finding that glycemic control in older age is especially sen-
sitive to treatment modality suggests that diabetes care 
should also focus on older adults who exhibit poor adher-
ence  to  medication  recommendations.  Furthermore,  the 
lower explanatory power of our model among older adults 
compared  with  that  among  middle-aged  adults  implies 
that in older age, glycemic control may be affected by more 
complex factors than during midlife. This finding supports 
the increasing body of literature advocating special consid-
erations for older adults with diabetes (23-26).
Our study has several limitations. First, although previ-
ous studies have found that the validity of self-reported 
exercise  behavior  is  high  among  older  adults  (27),  the 
validity  of  self-report  measures  of  substance  use  and 
weight  control  among  older  adults  remains  uncertain. 
Rates  of  performing  healthy  behaviors  may  have  been 
overestimated because of social desirability bias (28,29). 
Furthermore,  past  research  with  the  HRS  has  shown 
that, on average, survey respondents are healthier than 
nonrespondents (30); therefore, the relationship between 
modifiable  predictors  and  glycemic  control  may  appear 
stronger than it actually is. Second, although our prospec-
tive design allowed us to investigate predictors of HbA1c 
levels, the lack of baseline HbA1c data limited our ability 
to infer causal effects of our predictors of glycemic con-
trol. Third, we may have underestimated the explanatory 
effects of general lifestyle behaviors because other general 
lifestyle factors, such as psychologically related behaviors 
(eg, stress management, self-control) were not included. 
Fourth, the comparison of the predictive effects of some 
explanatory  variables  on  glycemic  control  in  the  2  age 
groups may be confounded with a “survival effect.” For 
example, less healthy members of minority groups may 
have died at earlier ages, leaving those surviving to age 65 
or older as relatively healthier, thus potentially underesti-
mating the effects of race/ethnicity on glycemic control in 
older age (30).
 
Overall, our results suggest that general lifestyle behav-
iors have a beneficial effect on glycemic control, beyond 
effects accounted for by demographic factors, clinical con-
ditions, and treatment modality, especially in middle-aged 
adults. Our findings provide support for current diabetes 
care guidelines that recommend a lifestyle regimen across 
the entire span of diabetes care and highlight the need 
to help sociodemographically or clinically disadvantaged 
middle-aged adults with type 2 diabetes and older adults 
who exhibit poor adherence to medication recommenda-
tions to achieve glycemic control.
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Tables
Table 1. Sample Characteristics and Bivariate Association With HbA1c Levels, Middle-Aged (51-64 y) and Older Adults (≥65 y) 
With Type 2 Diabetes (N = 809), the 1998 and 2000 Health and Retirement Study (HRS) and the HRS 2003 Diabetes Study
Characteristicsa %b Mean HbA1c Level,c % P Valued
Mean age (range, 51-89 y) 5. NA <.001
Sex
Male 50.0 7.27
.8
Female 50.0 7.29
Race/ethnicity
Non-Hispanic white 81.1 7.15
<.001 Non-Hispanic black 10.8 7.82
Hispanic/other 8.2 7.72
Mean years of education (range, 0-17 y) 11.8 NA .91
Marital status
Married/partnered 9.2 7.25
.1
Other 0.8 7.
Mean no. of chronic diseasese .0 NA <.001
Mean duration of diabetes (range, 1-42 y) 9.9 NA <.001
Treatment modality
Diet only 28.1 .75
<.001 Oral medication 50.9 7.
Insulin only or combination 21.0 7.8
Lifestylef
Poor .2 8.5
<.001 Fair . 7.
Good 2. 7.18
 
Abbreviations: HbA1c, hemoglobin A1c; NA, not applicable. 
a Data for mean age, sex, race/ethnicity, mean years of education, and marital status are from the 1998 HRS. Data for all other characteristics are from the 
2000 HRS. 
b All values are percentages unless otherwise indicated. 
c Data from the 200 Health and Retirement Study Diabetes Survey. 
d P values calculated using t test, analysis of variance (ANOVA), and simple regression; significance set at α = .05. 
e The number of chronic diseases was the sum of indicators for whether a participant had ever been informed by a doctor that he or she ever had high blood 
pressure, diabetes, cancer, lung disease, heart disease, stroke, psychiatric problems, or arthritis. 
f Poor = 0 positive health behaviors, fair = 1 positive health behavior, good ≥2 positive health behaviors.VOLUME 7: NO. 1
JANUARY 2010
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Table 2. Hierarchical Regression Analyses Predicting HbA1c Levels in Middle-Aged (51-64 y) and Older Adults (≥65 y) With 
Type 2 Diabetes (N = 809), the 1998 and 2000 Health and Retirement Study (HRS) and the HRS 2003 Diabetes Studya
Variable
Model 1b Model 2c Model 3d Model 4e
ß P Value ß P Value ß P Value ß P Value
Demographics
Age −.02 <.001 −.03 <.001 −.02 <.001 −.02 <.001
Race/ethnicity
  Non-Hispanic black .7 <.001 .57 <.001 .2 .008 .5 .005
  Hispanic .5 .002 .55 .002 . .001 .50 .00
  Non-Hispanic white 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Clinical Conditions
No. of chronic diseases — — .09 .0 .0 .2 .0 .2
Duration of diabetes — — .02 <.001 .01 .2 .01 .2
Treatment Modality
Diet only — — — — −1.17 <.001 −1.22 <.001
Oral medication — — — — −.50 <.001 −.55 <.001
Insulin only or combination — — — — 1 [Reference] 1 [Reference]
Lifestylef
Fair — — — — — — −1.21 <.001
Good — — — — — — −1.02 <.001
Poor — — — — — — 1 [Reference]
Fg 1.1 <.001 12.2 <.001 17.59 <.001 1.0 <.001
R2, % .80 — 7.2 — 1.09 — 1.18 —
∆R2, % — — 2.82 — .7 — 2.09 —
Fh — — .89 <.001 0.12 <.001 9.95 <.001
 
Abbreviation: HbA1c, hemoglobin A1c. 
a P values calculated using t test, analysis of variance (ANOVA), and simple regression; significance set at α = .05. 
b Model 1: demographic variables only. 
c Model 2: variables are demographics and clinical conditions. 
d Model : variables are demographics, clinical conditions, and treatment modality. 
e Model : variables are demographics, clinical conditions, treatment modality, and lifestyle. 
f Poor = 0 positive health behaviors, fair = 1 positive health behavior, good ≥2 positive health behaviors. 
g F test for model. 
h F test for change in R2.VOLUME 7: NO. 1
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Table 3. Hierarchical Regression Analyses Predicting HbA1c Levels in Middle-Aged Adults (51-64 y) With Type 2 Diabetes (N = 
379), the 1998 and 2000 Health and Retirement Study (HRS) and the HRS 2003 Diabetes Studya
Variable
Model 1b Model 2c Model 3d Model 4e
ß P Value ß P Value ß P Value ß P Value
Demographics (Race/Ethnicity)
Non-Hispanic black 1.1 <.001 .9 <.001 .82 .001 .80 .002
Hispanic .88 <.001 .87 .00 .7 .01 .79 .007
Non-Hispanic white 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Clinical Conditions
No. of chronic diseases — — .2 <.001 .19 .002 .18 .00
Duration of diabetes — — .0 <.001 .01 .2 .02 .0
Treatment Modality
Diet only — — — — −1.07 <.001 −1.18 <.001
Oral medication — — — — −.35 .11 −.46 .0
Insulin only or combination — — — — 1 [Reference] 1 [Reference]
Lifestylef
Fair — — — — — — −1.22 <.001
Good — — — — — — −.96 .008
Poor — — — — — — 1 [Reference]
Fg 12.90 <.001 1.8 <.001 12.82 <.001 11.0 <.001
R2, % .7 — 1. — 18.9 — 21.0 —
∆R2, % — — 7.77 — .05 — 2.81 —
Fh — — 1.98 <.001 9.2 <.001 .1 .001
 
Abbreviation: HbA1c, hemoglobin A1c. 
a P values calculated using t test, analysis of variance (ANOVA), and simple regression; significance set at α = .05. 
b Model 1: demographic variables only. 
c Model 2: variables are demographics and clinical conditions. 
d Model : variables are demographics, clinical conditions, and treatment modality. 
e Model : variables are demographics, clinical conditions, treatment modality, and lifestyle. 
f Poor = 0 positive health behaviors, fair = 1 positive health behavior, good ≥2 positive health behaviors. 
g F test for model. 
h F test for change in R2.VOLUME 7: NO. 1
JANUARY 2010
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Table 4. Hierarchical Regression Analyses Predicting HbA1c Levels in Older Adults (≥65 y) With Type 2 Diabetes (N = 430), 
the 1998 and 2000 Health and Retirement Study (HRS) and the HRS 2003 Diabetes Studya
Variable
Model 1b Model 2c Model 3d Model 4e
ß P Value ß P Value ß P Value ß P Value
Demographics
Race/ethnicity
Non-Hispanic black 0.1 .9 .17 .7 .09 .2 .11 .5
Hispanic .2 .25 .27 .20 .2 .2 .25 .21
Non-Hispanic white 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Clinical Conditions
No. of chronic diseases — — −.03 .5 −.07 .08 −.06 .1
Duration of diabetes — — .01 .2 −.01 .2 −.01 .2
Treatment Modality
Diet only — — — — −1.01 <.001 −1.07 <.001
Oral medication — — — — −.46 .001 −.46 .001
Insulin only or combination — — — — 1 [Reference] 1 [Reference]
Lifestylef
Fair — — — — — — −.90 .1
Good — — — — — — −.80 .18
Poor — — — — — — 1 [Reference]
Fg .80 .5 1.8 .25 7.18 <.001 5.71 <.001
R2, % .8 — 1. — 9.59 — 10.17 —
∆R2, % — — .9 — 8.25 — 0.58 —
Fh — — 2.07 .1 19.0 <.001 1. .2
 
Abbreviation: HbA1c, hemoglobin A1c. 
a P values calculated using t test, analysis of variance (ANOVA), and simple regression; significance set at α = .05. 
b Model 1: demographic variables only. 
c Model 2: variables are demographics and clinical conditions. 
d Model : variables are demographics, clinical conditions, and treatment modality. 
e Model : variables are demographics, clinical conditions, treatment modality, and lifestyle. 
f Poor = 0 positive health behaviors, fair = 1 positive health behavior, good ≥2 positive health behaviors. 
g F test for model. 
h F test for change in R2. 